
|Videos|September 14, 2022
WellDyne's David Skomo Highlights the Need to Reframe How Obesity Is Viewed
Author(s)Laura Joszt, MA, Peter Wehrwein
Payers need to reframe how they view obesity as not just a health and wellness issue, but as a progressive chronic disease that needs medication, explained David Skomo, RPh, chief operations officer at WellDyne.
Advertisement
Over 70% of U.S. adults are struggling with their weight, and obesity is linked to 60 comorbidities, noted David Skomo, RPh, chief pharmacy operations officer, WellDyne. Given the growing obesity problem, payers need to reframe how they view the disease as not just a health and wellness issue, but as a progressive chronic disease that needs medication.
Skomo presented on coverage of obesity treatments on the last day of the 2022 PBMI Annual National Conference in Orlando, Florida.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
2
Zepbound linked to lower healthcare costs in older adults with obesity
3
FDA approves brepocitinib for rare skin disease
4
Employer health care costs projected to rise 9.5% in 2027, report finds
5













